Aventaa | Where Science Meets Precision At Aventaa, we are not service providers — we are R&D partners driving pharmaceutical innovation. As a specialized Contract Research Organization (CRO), we focus exclusively on high-precision custom synthesis of impurities, peptides, and complex molecules for the global pharmaceutical industry. Our strength lies in deep scientific expertise, speed of execution, and uncompromising quality standards. We enable pharma companies to accelerate drug development, meet stringent regulatory requirements, and reduce time-to-market without compromising accuracy or compliance. What Defines Aventaa Advanced custom synthesis of impurities & peptides Strong R&D capabilities for complex molecule development Fast, reliable, and compliance-driven CRO execution Built for precision, scalability, and regulatory alignment We don’t operate as vendors — we integrate as an extension of your R&D team, solving critical scientific challenges with clarity and control. At Aventaa, we don’t just deliver results — we deliver certainty in research, confidence in compliance, and speed in innovation.
| Website | https://aventaa.com |
| Employees | 15 (9 on RocketReach) |
| Founded | 2025 |
| Industry | Research Services |
Looking for a particular Aventaa Research employee's phone or email?
Punit Mehta is the Co-Founder and Director of Aventaa Research.
9 people are employed at Aventaa Research.